#Thinksabio latest news
KYTX – Kyverna Therapeutics Appoints Mayo Pujols as Chief Technology OfficerMr. Pujols brings more than 30 years of technical operations expertise to role, scaling commercial manufacturing for CAR T-cell therapies and complex biologics, as Kyverna advances towards launch of miv-cel